MedPath

The Effect of Mastiha Oil in Metabolic Syndrome

Not Applicable
Completed
Conditions
Metabolic Syndrome
Interventions
Dietary Supplement: Mastiha oil
Registration Number
NCT04785573
Lead Sponsor
Harokopio University
Brief Summary

Mastiha Oil is a 100% natural product of the Mediterranean, extracted from the resin of Mastiha. Over 90 compounds have been identified in Mastiha oil, with monoterpenes exhibiting favorable effects in regulating mechanisms of oxidative stress and inflammation. The aim of this study is to determine the effect of Mastiha oil in adults with Metabolic Syndrome. 90 participants will be allocated to two groups, (45 in intervention group and 45 in control group). Mastiha oil will be provided in the form of soft gel capsules to the intervention group, whereas the control group will not consume the capsules. Both groups will receive standard nutritional counselling. The intervention will last 3 months.

The effects of the intervention will be evaluated via clinical and laboratory markers.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
94
Inclusion Criteria
  • 30 years < Age < 75 years
  • Metabolic Syndrome cardiometabolic parameters
  • A stable weight for ≥ 3 months pre-intervention
  • An unchanged treatment regimen for ≥ 6 months pre-intervention
Exclusion Criteria
  • Hepatotoxic Medication
  • Untreated Diabetes Mellitus
  • Dysthyroidism, hypopituitarism, Cushing syndrome / disease
  • Pregnancy, lactation
  • Psychiatric or mental disorder
  • Any use of antioxidant-phytochemical rich supplement, vitamin D supplement, anti-, pre- or pro-biotics within 3 months pre-intervention

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention groupMastiha oilParticipants with metabolic disorders will be subjected to nutritional counsel and the intake of 1 soft gel capsule daily for a total of 3 months.
Primary Outcome Measures
NameTimeMethod
Change in insulin sensitivity3 months

Levels will be evaluated pre and prost intervention in both control and intervention groups

Change in blood LDL3 months

Levels will be evaluated pre and prost intervention in both control and intervention groups

Change in blood total cholesterol3 months

Levels will be evaluated pre and prost intervention in both control and intervention groups

Change in blood triglycerides3 months

Levels will be evaluated pre and prost intervention in both control and intervention groups

Secondary Outcome Measures
NameTimeMethod
Change in blood CRP3 months

Levels will be evaluated pre and prost intervention in both control and intervention groups

Change in blood IL-63 months

Levels will be evaluated pre and prost intervention in both control and intervention groups

Change in blood MPO3 months

Levels will be evaluated pre and prost intervention in both control and intervention groups

Change in blood antioxidant potential3 months

Levels will be evaluated pre and prost intervention in both control and intervention groups

Trial Locations

Locations (2)

Harokopio University

🇬🇷

Athens, Attica, Greece

Andriana Kaliora

🇬🇷

Athens, Greece

© Copyright 2025. All Rights Reserved by MedPath